Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study()

BACKGROUND: The aim of this study was to evaluate the safety, tolerability, and efficacy of a brand-generic glatiramer acetate product in patients with relapsing-remitting multiple sclerosis over a 12-month period. A noninterventional cohort study was conducted on 185 patients. The patients had a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolfazli, Roya, Pournourmohammadi, Shirin, Shamshiri, Ahmadreza, Samadzadeh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008499/
https://www.ncbi.nlm.nih.gov/pubmed/29928468
http://dx.doi.org/10.1016/j.curtheres.2018.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008499/
https://www.ncbi.nlm.nih.gov/pubmed/29928468
http://dx.doi.org/10.1016/j.curtheres.2018.05.001

Ejemplares similares